Why Bausch Health Companies Stock Zoomed 8% Higher Today

Why Bausch Health Companies Stock Zoomed 8% Higher Today

Bausch Health Companies (NYSE: BHC) was a very healthy stock Wednesday. Analyst Chris Schott from JPMorgan Chase's J.P. Morgan pointed out in his note that a sum-of-the-parts calculation indicates to him that Bausch stock could be worth around $40 (although he's maintaining his $38 price target). The prognosticator is also maintaining his overweight (buy) recommendation on the stock.